DrugPatentWatch Database Preview

Synthon Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for SYNTHON PHARMS, and what generic alternatives to SYNTHON PHARMS drugs are available?

SYNTHON PHARMS has twelve approved drugs.

There is one US patent protecting SYNTHON PHARMS drugs. There are four tentative approvals on SYNTHON PHARMS drugs.

There are four patent family members on SYNTHON PHARMS drugs in four countries and thirty-four supplementary protection certificates in ten countries.

Summary for Synthon Pharms

International Patents:	4
US Patents:	1
Tradenames:	10
Ingredients:	10
NDAs:	12

Drugs and US Patents for Synthon Pharms

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Synthon Pharms	ZOLPIDEM TARTRATE	zolpidem tartrate	TABLET;ORAL	077540-002	Apr 23, 2007		DISCN	No	No
Synthon Pharms	RISPERIDONE	risperidone	TABLET;ORAL	078187-002	Oct 22, 2009		DISCN	No	No
Synthon Pharms	AMLODIPINE BESYLATE	amlodipine besylate	TABLET;ORAL	077080-001	Jun 27, 2007		DISCN	No	No
Synthon Pharms	AMLODIPINE BESYLATE	amlodipine besylate	TABLET;ORAL	077080-003	Jun 27, 2007		DISCN	No	No
Synthon Pharms	RISPERIDONE	risperidone	TABLET;ORAL	078187-001	Oct 22, 2009		DISCN	No	No
Synthon Pharms	RISPERIDONE	risperidone	TABLET;ORAL	078187-003	Oct 22, 2009		DISCN	No	No

Premature patent expirations for SYNTHON PHARMS

Expiration due to failure to pay maintenance fee

Patent Number	Expiration Date

International Patents for Synthon Pharms Drugs

Country	Document Number	Estimated Expiration
European Patent Office	1448197
Argentina	037565
Australia	2002343257
World Intellectual Property Organization (WIPO)	03043635

Supplementary Protection Certificates for Synthon Pharms Drugs

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2015 00004	Denmark		PRODUCT NAME: ZOLPIDEM OG FARMACEUTISK ACCEPTABLE SALTE HERAF, HERUNDER ZOLPIDEMTARTRAT; NAT. REG. NO/DATE: 47607 OG 47608 20120719; FIRST REG. NO/DATE: (B BE424286 OG BE424295 20120718
00172	Netherlands		PRODUCT NAME: EZETIMIBE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, EN SIMVASTATINE; NAT. REGISTRATION NO/DATE: RVG 30927RVG 30928RVG 30929RVG 30930 2004221122; FIRST REGISTRATION: 58874.00.0058874.01.0058874.02.0058874.03.0058878.00.0058878.01.0058878.02.0058878.03.0058866.00.0058866.01.0058866.02.0058866.03.0058870.00.0058870.01.0058870.02.0058870.03.00 2004020402
00375	Netherlands		PRODUCT NAME: COMBINATIE VAN OLMESARTAN MEDOXOMIL, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT EN AMLODIPINEBESILAAT; REGISTRATION NO/DATE: RVG100984, RVG100986-87, RVG100989-91, RVG100993-95 20080819
C0055	France		PRODUCT NAME: ANASTROZOLE, EVENTUELLEMENT SOUS LA FORME D’UN SEL D’ADDITION ACCEPTABLE EN MEDECINE PHARMACEUTIQUE; REGISTRATION NO/DATE IN FRANCE: NL 21126 DU 19961227; REGISTRATION NO/DATE AT EEC: 12619/0106 DU 19950811
2015000006	Germany		PRODUCT NAME: ZOLPIDEM UND PHARMAZEUTISCH VERTRAEGLICHE SALZE DAVON; NAT. REGISTRATION NO/DATE: 83439.00.00 83440.00.00 20120725 FIRST REGISTRATION: BELGIEN BE424286 BE424295 20120718
/2005	Austria		PRODUCT NAME: EZETIMIB ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON KOMBINIERT MIT SIMVASTATIN; NAT. REGISTRATION NO/DATE: 1-25673 - 1-25676 20041228; FIRST REGISTRATION: DE 58874.00.00 - 58874.03.00; 58878.00.00 - 20040402

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Synthon Pharms